Stemtech Corporation Announces Go Live of Stemtech Advance Office Based on VERB Technology Monday Sep 19
September 14 2022 - 09:00AM
GlobeNewswire Inc.
Stemtech Corporation (“Stemtech”) (OTCQB: STEK),
an innovative nutraceutical company and a pioneer in the field of
stem cell nutrition, today announced the Go-Live date of their
Stemtech Advance Office based on the VERB Technology Company, Inc.
(NASDAQ: VERB) system.
Stemtech Corporation President and Chief
Operating Officer, John W. Meyer, said “we are extremely happy to
announce go-live for Monday, September 19, 2022. It is with great
anticipation that we offer this exceptional, leading-edge industry
software as a tremendous communication tool for our Independent
Business Partners (IBPs). We are proud to have this partnership
with VERB, who provide Stemtech with direct sales recruiting,
retention and expansion of business capabilities. The analytics and
communication aspects via their interactive video-based sales
applications, including live-streaming, are a powerful means to
communicate with new prospective customers. This partnership with
such a prominent provider is an exciting step and will help drive
momentum for Stemtech.”
About Stemtech Corporation
Stemtech Corporation, a leading nutraceutical
company with a direct sales distribution model, was founded on
April 18, 2018, after acquiring the operations from its predecessor
Stemtech International, Inc. which was founded in 2005. From 2010
through 2015, Stemtech International, Inc., was recognized four
separate times on the Inc. 5000 Fastest-Growing Companies list. In
2018, the Company underwent an extensive executive reorganization,
and continued operations under new leadership. Stemtech specializes
in creating products and formulas that are patent protected in the
U.S. and in select international markets. The Company’s patented
formulas help the release, circulation and migration of the body’s
adult stem cells from its bone marrow. The Company markets its
products under the following brands: RCM System, stemrelease3™,
Stemflo® MigraStem, OraStem® (Oral Health Care), and D-Fuze™ (EMF
blocker). Its nutraceutical products are all-natural, plant-based
and manufactured under cGMP (Current Good Manufacturing Practices)
under the auspices of the Dietary Supplement Health and Education
Act (DSHEA). For more information, please visit
www.stemtech.com.
About VERB Technology
Verb Technology Company, Inc. (Nasdaq: VERB),
the market leader in interactive video-based sales applications,
transforms how businesses attract and engage customers. The
Company’s Software-as-a-Service, or SaaS, platform is based on its
proprietary interactive video technology, and is comprised of a
suite of sales enablement business software products offered on a
subscription basis. Its software applications are used by hundreds
of thousands of people in over 100 countries and in more than 48
languages. VERB’s clients include large sales-based enterprises as
well as small business sales teams, including the sales and
marketing departments of professional sports teams. MARKET.live is
VERB’s multi-vendor, multi-presenter, livestream social shopping
platform at the forefront of the convergence of ecommerce and
entertainment. With approximately 150 employees and contractors,
the Company is headquartered in Lehi, Utah, and also maintains
offices in Newport Beach, California.
Forward-Looking Statements
This announcement contains forward-looking
statements within the meaning of the “safe harbor” provisions of
the U.S. Private Securities Litigation Reform Act of 1995. Such
statements include but are not limited to statements identified by
words such as "believes," "expects," "anticipates," "estimates,"
"intends," "plans," "targets," "projects" and similar expressions.
The statements in this release are based upon the current beliefs
and expectations of our company's management and are subject to
significant risks and uncertainties. Actual results may differ from
those set forth in the forward-looking statements. Numerous factors
could cause or contribute to such differences, including, but not
limited to, results of clinical trials and/or other studies, the
challenges inherent in new product development initiatives, the
effect of any competitive products, our ability to license and
protect our intellectual property, our ability to raise additional
capital in the future that is necessary to maintain our business,
changes in government policy and/or regulation, potential
litigation by or against us, any governmental review of our
products or practices, as well as other risks discussed from time
to time in our filings with the Securities and Exchange Commission,
including, without limitation, our latest 10-Q Report filed
on August 23, 2022. We undertake no duty to update any
forward-looking statement, or any information contained in this
press release or in other public disclosures at any time. Finally,
the investing public is reminded that the only announcements or
information about Stemtech Corporation which are condoned by the
Company must emanate from the Company itself and bear our name as
its Source.
www.Stemtech.com
Investor Relations:
Frank J. Pena, 908
675-0581
fpena@stemtech.com
Verb Technology (NASDAQ:VERB)
Historical Stock Chart
From Jan 2023 to Feb 2023
Verb Technology (NASDAQ:VERB)
Historical Stock Chart
From Feb 2022 to Feb 2023